Thomas Jefferson University
News Articles
Edith Mitchell, M.D., clinical professor of Medicine and Medical Oncology at Jefferson Medical College of Thomas Jefferson University, was honored with the 2009 National Medical Association Council on Concerns of Women Physicians Pfizer Research Award.
The award is given to a woman who has made outstanding contributions to clinical or academic medicine. It was presented at the Muriel Petioni, M.D. Awards Luncheon, which took place at the National Medical Association Convention in Las Vegas in July. Female physicians who strive to eliminate health care disparities and provide quality health care to minorities are honored.
“This is a great honor as there are so many women physicians who are also deserving of this award,” said Dr. Mitchell, who is also Associate Director for Diversity Programs at the Kimmel Cancer Center at Jefferson.
Dr. Mitchell received a bachelor of science in Biochemistry “With Distinction” from Tennessee State University and her medical degree from the Medical College of Virginia in Richmond. Dr. Mitchell entered active duty after completion of her internship and residency in Internal Medicine at Meharry Medical College and a fellowship in Medical Oncology at Georgetown University. She is now a retired Brigadier General from the United States Air Force.
Dr. Mitchell’s research in pancreatic cancer and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined modality therapy, patient selection criteria and supportive care for patients with gastrointestinal cancer. She travels nationally and internationally teaching and lecturing on the treatment of gastrointestinal malignancies.
Dr. Mitchell has authored and co-authored more than 100 articles, book chapters, and abstracts on cancer treatment, prevention, and cancer control. As a distinguished researcher, she has received numerous Cancer Research and Principal Investigator Awards, and serves on the National Cancer Institute Review Panel and the Cancer Investigations Review Committee.
